Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1654 1658 1676
This examiner grants 41% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18250406 | PEPTIDE TAG AND TAGGED PROTEIN CONTAINING SAME | Non-Final OA | IDEMITSU KOSAN CO.,LTD. |
| 18350803 | PEPTIDE DISINFECTANT FOR PREVENTING CORONAVIRUSES | Non-Final OA | Xiamen University |
| 17288879 | SYNTHETIC PEPTIDES INDUCING IMMUNOGENIC CELL DEATH | Final Rejection | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE |
| 18041289 | PEPTIDES AND FORMULATIONS FOR CANCER TREATMENT | Non-Final OA | Peptinovo Biopharma, Inc. |
| 18246063 | POLYMERS AND NANOPARTICLE FORMULATIONS FOR SYSTEMIC NUCLEIC ACID DELIVERY | Non-Final OA | The Johns Hopkins University |
| 18449907 | IODINATED CROSSLINKED HYDROGELS AND METHODS OF FORMING THE SAME | Non-Final OA | Boston Scientific Scimed, Inc. |
| 17628142 | SEPARATED PEPTIDE | Non-Final OA | National University Corporation Tokai National Higher Education and Research System |
| 18000853 | PROCESS FOR PREPARING A GLP-1/GLUCAGON DUAL AGONIST | Final Rejection | Eli Lilly and Company |
| 17418305 | METHOD FOR STABILIZING BIOACTIVITY OF GROWTH FACTOR | Final Rejection | National Cheng Kung University |
| 18717568 | PEPTIDES AND COMPOSITIONS FOR USE IN COSMETICS | Final Rejection | LIPOTRUE, S.L. |
| 18620789 | METHODS FOR THE TREATMENT OF AGE-RELATED MACULAR DEGENERATION | Final Rejection | Stealth BioTherapeutics Inc. |
| 18460346 | METHODS AND COMPOSITIONS FOR TREATING, PREVENTING, INHIBITING, AMELIORATING OR DELAYING THE ONSET OF OPHTHALMIC CONDITIONS | Non-Final OA | Stealth BioTherapeutics Inc. |
| 18233783 | METHOD FOR TREATING CANCER EXPRESSING SPARC | Final Rejection | SEOUL NATIONAL UNIVERSITY HOSPITAL |
| 18131280 | PEPTIDIC OLIGOMERS AND METHODS OF USING THE SAME | Non-Final OA | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ARKANSAS |
| 18037287 | PROTEIN HYDROGELS AND METHODS FOR THEIR PREPARATION | Non-Final OA | THE UNIVERSITY OF BRITISH COLUMBIA |
| 18593433 | PEPTIDE COMPOUND, APPLICATION THEREOF AND COMPOSITION CONTAINING SAME | Final Rejection | XDCEXPLORER (SHANGHAI) CO., LTD. |
| 18002478 | LONG ACTING GLP-1/GIP DUAL AGONISTS | Non-Final OA | SUN PHARMACEUTICAL INDUSTRIES LIMITED |
| 17616809 | ANTI-INFLAMMATORY AGENTS | Non-Final OA | The University of Sydney |
| 18492014 | INSECT NEUROPEPTIDES 7 | Non-Final OA | Solasta Bio Limited |
| 16104037 | Composition and Method for Therapeutic Agent Delivery During Pregnancy | Non-Final OA | University of Mississippi Medical Center |
| 15694592 | MOLECULAR SENSORS | Final Rejection | UNIVERSITY COLLEGE DUBLIN, NATIONAL UNIVERSITY OF IRELAND, DUBLIN |
| 18271663 | POLYPEPTIDE FOR REPAIRING SKIN WOUND OR MUCOSAL INJURY, AND APPLICATION THEREOF | Non-Final OA | Sichuan Gooddoctor Panxi Pharmaceutical Co., Ltd. |
| 17252038 | BICYCLIC PEPTIDE LIGANDS SPECIFIC FOR NECTIN-4 | Non-Final OA | BicycleTx Limited |
| 18270097 | HUMAN GLP-1 POLYPEPTIDE VARIANT AND USE THEREOF | Non-Final OA | SUZHOU ALPHAMAB CO., LTD |
| 17629313 | PEPTIDE HAVING HAIR GROWTH PROMOTING ACTIVITY, AND USE THEREOF | Final Rejection | CAREGEN CO., LTD. |
| 18097077 | PEPTIDE INHIBITORS OF INTERLEUKIN-23 RECEPTOR AND THEIR USE TO TREAT INFLAMMATORY DISEASES | Final Rejection | Protagonist Therapeutics, Inc. |
| 18021391 | AN IMPROVED PROCESS FOR FMOC SYNTHESIS OF ETELCALCETIDE | Final Rejection | USV Private Limited |
| 17996875 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING CANCER | Final Rejection | L-BASE CO., LTD. |
| 17918930 | NOVEL ALPHA-HELICAL DOUBLE-SIDED CELL PENETRATING PEPTIDE AND USE THEREOF | Final Rejection | CAMP THERAPEUTICS INC. |
| 17995092 | NOVEL ANTIBACTERIAL PEPTIDE AND USE THEREOF | Final Rejection | ANYGEN CO., LTD. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy